ArticleOncotarget2016

Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC.

Fahmin Basher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.